Literature DB >> 27283931

The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung Cancer.

Willem Grootjans1,2, Florent Tixier2,3, Charlotte S van der Vos2, Dennis Vriens4, Catherine C Le Rest3, Johan Bussink5, Wim J G Oyen6, Lioe-Fee de Geus-Oei7, Dimitris Visvikis8, Eric P Visser2.   

Abstract

Accurate measurement of intratumor heterogeneity using parameters of texture on PET images is essential for precise characterization of cancer lesions. In this study, we investigated the influence of respiratory motion and varying noise levels on quantification of textural parameters in patients with lung cancer.
METHODS: We used an optimal-respiratory-gating algorithm on the list-mode data of 60 lung cancer patients who underwent 18F-FDG PET. The images were reconstructed using a duty cycle of 35% (percentage of the total acquired PET data). In addition, nongated images of varying statistical quality (using 35% and 100% of the PET data) were reconstructed to investigate the effects of image noise. Several global image-derived indices and textural parameters (entropy, high-intensity emphasis, zone percentage, and dissimilarity) that have been associated with patient outcome were calculated. The clinical impact of optimal respiratory gating and image noise on assessment of intratumor heterogeneity was evaluated using Cox regression models, with overall survival as the outcome measure. The threshold for statistical significance was adjusted for multiple comparisons using Bonferroni correction.
RESULTS: In the lower lung lobes, respiratory motion significantly affected quantification of intratumor heterogeneity for all textural parameters (P < 0.007) except entropy (P > 0.007). The mean increase in entropy, dissimilarity, zone percentage, and high-intensity emphasis was 1.3% ± 1.5% (P = 0.02), 11.6% ± 11.8% (P = 0.006), 2.3% ± 2.2% (P = 0.002), and 16.8% ± 17.2% (P = 0.006), respectively. No significant differences were observed for lesions in the upper lung lobes (P > 0.007). Differences in the statistical quality of the PET images affected the textural parameters less than respiratory motion, with no significant difference observed. The median follow-up time was 35 mo (range, 7-39 mo). In multivariate analysis for overall survival, total lesion glycolysis and high-intensity emphasis were the two most relevant image-derived indices and were considered to be independent significant covariates for the model regardless of the image type considered.
CONCLUSION: The tested textural parameters are robust in the presence of respiratory motion artifacts and varying levels of image noise.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  18F-FDG PET/CT; lung cancer; radiomics; respiratory gating; total lesion glycolysis

Mesh:

Substances:

Year:  2016        PMID: 27283931     DOI: 10.2967/jnumed.116.173112

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  27 in total

Review 1.  Towards precision medicine: from quantitative imaging to radiomics.

Authors:  U Rajendra Acharya; Yuki Hagiwara; Vidya K Sudarshan; Wai Yee Chan; Kwan Hoong Ng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

2.  Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis.

Authors:  Alex Zwanenburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-25       Impact factor: 9.236

3.  Clinical perspectives for the use of total body PET/CT.

Authors:  Ronan Abgral; David Bourhis; Pierre-Yves Salaun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06       Impact factor: 9.236

Review 4.  Texture analysis of medical images for radiotherapy applications.

Authors:  Elisa Scalco; Giovanna Rizzo
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

Review 5.  Radiomics: the bridge between medical imaging and personalized medicine.

Authors:  Philippe Lambin; Ralph T H Leijenaar; Timo M Deist; Jurgen Peerlings; Evelyn E C de Jong; Janita van Timmeren; Sebastian Sanduleanu; Ruben T H M Larue; Aniek J G Even; Arthur Jochems; Yvonka van Wijk; Henry Woodruff; Johan van Soest; Tim Lustberg; Erik Roelofs; Wouter van Elmpt; Andre Dekker; Felix M Mottaghy; Joachim E Wildberger; Sean Walsh
Journal:  Nat Rev Clin Oncol       Date:  2017-10-04       Impact factor: 66.675

6.  Locally advanced rectal cancer: predicting non-responders to neoadjuvant chemoradiotherapy using apparent diffusion coefficient textures.

Authors:  Ming Liu; Han Lv; Li-Heng Liu; Zheng-Han Yang; Er-Hu Jin; Zhen-Chang Wang
Journal:  Int J Colorectal Dis       Date:  2017-05-11       Impact factor: 2.571

Review 7.  Respiratory-gated PET/CT for pulmonary lesion characterisation-promises and problems.

Authors:  Russell Frood; Garry McDermott; Andrew Scarsbrook
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

Review 8.  The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer.

Authors:  Tom Konert; Jeroen B van de Kamer; Jan-Jakob Sonke; Wouter V Vogel
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

Review 9.  Quantification of Lung PET Images: Challenges and Opportunities.

Authors:  Delphine L Chen; Joseph Cheriyan; Edwin R Chilvers; Gourab Choudhury; Christopher Coello; Martin Connell; Marie Fisk; Ashley M Groves; Roger N Gunn; Beverley F Holman; Brian F Hutton; Sarah Lee; William MacNee; Divya Mohan; David Parr; Deepak Subramanian; Ruth Tal-Singer; Kris Thielemans; Edwin J R van Beek; Laurence Vass; Jeremy W Wellen; Ian Wilkinson; Frederick J Wilson
Journal:  J Nucl Med       Date:  2017-01-12       Impact factor: 10.057

Review 10.  Machine and deep learning methods for radiomics.

Authors:  Michele Avanzo; Lise Wei; Joseph Stancanello; Martin Vallières; Arvind Rao; Olivier Morin; Sarah A Mattonen; Issam El Naqa
Journal:  Med Phys       Date:  2020-06       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.